Pre-market Hot Trades in US Stocks
Urban-Gro is up 7.14% in pre-market trading. Based on recent key news:
<ol>
<li>
On April 27, Urban-Gro announced a strategic transformation into a sports, media, and experiential marketing platform. This move is seen by the market as an important step in diversifying the company's business, driving the stock price up.
</li>
<li>
On April 25, technical sentiment signals indicated a sell, and the market is cautious about Urban-Gro's technical outlook, which may affect short-term trading behavior.
</li>
<li>
On April 27, the company issued a forward-looking statement emphasizing that it does not undertake any obligation to update or revise the statement, increasing market attention on future uncertainties. The industry transformation has attracted market attention, with noticeable capital inflows.
</li>
</ol>
Oracle is down 5.30% in pre-market trading. Based on recent key news:
<ol>
<li>
On April 28, Oracle announced a partnership with BorderPlex Digital Assets to power its AI data centers using Bloom Energy's fuel cells. This move aims to reduce emissions and lower water usage, enhancing the project's environmental benefits.
</li>
<li>
On April 25, Oracle completed $16 billion in financing for its data center project in Michigan, demonstrating market confidence in its AI infrastructure investments.
</li>
<li>
On April 25, Wedbush Securities rated Oracle as &#34;Outperform&#34; with a target price of $225, emphasizing its strategic transformation in the AI and cloud computing sectors. The surge in AI infrastructure investment has led to increased debt financing.
</li>
</ol>
Top Gainers in Pre-market US Stocks
Direct Digital is up 45.31% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
Calidi Biotherapeutics is up 41.47% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
Profusa is up 26.62% in pre-market trading. Based on recent key news:
<ol>
<li>
On April 24, Profusa Inc. released the latest announcement through the EDGAR system of the U.S. Securities and Exchange Commission, announcing that its new product has received FDA approval. This news significantly raised market expectations for the company's future growth, driving the stock price up sharply.
</li>
<li>
On April 23, Profusa Inc. signed a strategic cooperation agreement with a large medical device company to jointly develop next-generation biosensing technology. This move is seen by the market as an important step in expanding the company's business scope, further boosting investor confidence.
</li>
<li>
On April 22, analysts generally raised their earnings forecasts for Profusa Inc., expecting its new products to bring significant revenue growth. Analysts' optimistic expectations have enhanced market confidence in the company's future performance, driving the stock price up. The medical device industry has performed strongly recently, with noticeable capital inflows
</li>
</ol>

UGRO

ORCL

Urban-Gro pre-market up 7.14%; Oracle pre-market down 5.30%; Direct Digital pre-market up 45.31%; Calidi Biotherapeutics pre-market up 41.47%; Profusa pre-market up 26.62%

Price Alert

Urban-Gro

Pre-market hot trades in US stocks: Urban-Gro up 7.14% in pre-market; Oracle down 5.30% in pre-market